Identifying Factors Underlying the Discontinuation of Triptans
NCT ID: NCT00890357
Last Updated: 2013-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
292 participants
OBSERVATIONAL
2009-08-31
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Treatment Used for Migraine Headaches (MK-0974-076)
NCT01421277
Facilitating Migraine Medication Adherence and Optimizing Medication Use
NCT02473692
One-Day Intervention for Depression and Impairment in Migraine Patients
NCT02108678
Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine
NCT01435941
Non-pharmacological Treatments in Migraine.
NCT05596058
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Triptan User
No interventions assigned to this group
Triptan Discontinued
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have used a triptan medication in the prior 3 months
* Have used triptan medications for at least 1 year
* Episodic Migraine or Chronic Migraine
* Used any triptan medication in the last 2 years
* Have not used a triptan medication in the last 6 months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Merck Sharp & Dohme LLC
INDUSTRY
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Todd J. Schwedt
PI
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Todd Schwedt, MD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of South Florida College of Medicine
Tampa, Florida, United States
Washington University School of Medicine
St Louis, Missouri, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wells RE, Markowitz SY, Baron EP, Hentz JG, Kalidas K, Mathew PG, Halker R, Dodick DW, Schwedt TJ. Identifying the factors underlying discontinuation of triptans. Headache. 2014 Feb;54(2):278-89. doi: 10.1111/head.12198. Epub 2013 Sep 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-0111
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.